ZoeNCure Therapeutics raises $2.1M seed

◆ Amount

$2.1M

◆ Announced

3 Oct 2026

◆ Company

◆ Source

◆ The Round

ZoeNCure Therapeutics raised $2.1M in seed funding, announced on 3 October 2026, led by Tyagi Family, with participation from Angel co-investors. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About ZoeNCure Therapeutics

Delhi-based oncology biotechnology startup developing high-potency targeted cancer therapies, with focus on hard-to-treat liver and gastrointestinal cancers using antibody drug conjugates. ZoeNCure Therapeutics is based in India and currently at seed stage, operating in Biotech.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links ZoeNCure Therapeutics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market